Home Featured Page 162

Featured

Latest

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Optimi Health Provides Progress Report On Year Of Commercialization

FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN...

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of...

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine...

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment...

Optimi Health Enters Into International Collaborative Research and Supply Agreement With...

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Mindset Pharma to Participate in the H.C. Wainwright 24th Annual Global...

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....

EDITOR PICKS

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future...

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Optimi Health Provides Progress Report On Year Of Commercialization

FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN...

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of...

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine...

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment...

Optimi Health Enters Into International Collaborative Research and Supply Agreement With...

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Mindset Pharma to Participate in the H.C. Wainwright 24th Annual Global...

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....

EDITOR PICKS

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future...

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY